All Conferences on Cree Board of Health
(13 records)
Page 1 of 2Next>
Sort by :    
May 17, 2019

DIABETES UPDATE FOR NORTHERN MDS 2019: WOUND CARE AND OSTEO IN DM2

  • Understand the clinical management of skin and soft tissue infections (SSTI) and osteomyelitis, including those from MRSA
  • Be familiar approaches to screening and decolonisation of MRSA
  • Know when to suspect less common causes of skin and soft tissue infections
  • Be more comfortable evaluating clinical response to treatment
Dr. Cédric Yansouni, MD, FRCPC, DTM&H
diabetes, infections, osteomyelitis, soft tissue infections
May 17, 2019

DIABETES UPDATE FOR NORTHERN MDS 2019: THE NEW CHB DIABETES IN PREGNANCY GUIDELINES

  • At the conclusion of the session, participants will understand how and why CHB is different from Canadian Diabetes Association GDM guidelines
  • At the conclusion of the session, participants will understand the new term “High Risk of GDM” and how to manage it without making the patient crazy…
  • At the end of the session the participants will understand the urgency for treatment of DM2 in pregnancy (and why it is ok to make the patient a little bit crazy… ! )
Dr. David Dannenbaum, Dr. Marie Carmen Berlie and Helene Porada
May 17, 2019

WHAT JAMES BAY CREE STORYTELLERS TALK ABOUT WHEN THEY TALK ABOUT DIABETES.

Drawing on Sweet Bloods of Eeyou Istchee: Stories of Diabetes and the James Bay Cree (which I wrote), and on conversations with Cree participants living with diabetes, I will discuss how the participants understood and talked about their own diabetes.
Dr. Ruth Dyck Fehderuau
May 17, 2019

DIABETES UPDATE FOR NORTHERN MDS 2019: INDIVIDUALIZING DIABETES CARE: GLUCOSE CONTROL AND BEYOND

T2DM management requires lifestyle changes and pharmacotherapy to not only lower blood glucose but also reduce cardiovascular risk factors, and address comorbidities.
Care needs to be responsive to individuals' unique needs and preference as successful diabetes care requires a patient’s consistent self-care.

Learning Objectives:

  • To identify patient psychosocial and clinical factors to consider in tailoring T2DM management.
  • To review glucose-lowering medications and their non-glycemic effects.
  • To recognize need for multifactorial risk reduction to prevent CVD and death in diabetic patients.
Dr. Romina Pace
T2DM management, glucose-lowering medications and their non-glycemic effects, multifactorial risk, prevent CVD, prevent death in diabetic patients
Jun 08, 2018

SWEET BLOOD SEEBAI

  • Understand patient perspectives.
  • Treat the person not the numbers, and the numbers will come down!
  • Review preDM and diabetes prevention
  • Come out of it as better health care workers
David Dannenbaum MD, CCFP
diabeties indigenous, management
Jun 08, 2018

EARLY GESTATIONAL DIABETES MELLITUS (GDM)?

  • Review rationale for 2012 CBHSSJB Hyperglycemia in Pregnancy guidelines
  • Understand significance of eGDM
David Dannenbaum MD, CCFP
Jun 08, 2018

TYPE 2 DIABETES IN YOUTH: EPIDEMIOLOGY, TREATMENT AND EARLY LIFE DETERMINANTS

Dr. Sellers will briefly review the epidemiology of youth onset type 2 diabetes and focus on treatment and early life determinents of this emerging epidemic. Learning Objectives:
  • Review the epidemiology of childhood onset type 2 diabetes in Indigenous youth
  • To explore the reasons for an increased burden in Indigenous children
  • Develop an approach to treatment
  • Understand barriers to care
  • Explore early life determinants
Elizabeth Sellers MD MSc FRCPC
Type 2 diabetes, Children, Adolescents, Indigenous
Jun 08, 2018

NEW DIABETIC AGENTS... WHAT TO CHOSE?

  • Review current therapies to treat type 2 diabetes mellitus with emphasis on new agents
  • Review new landmark cardiovascular safety trials
  • Review 2018 CDA guidelines with respect to new targets for glycemic control
  • Provide some framework for choosing amongst the different agents
  • Review insulin initiation and the new insulins
Natasha Garfield, MDCM, FRCP(C)
diabetes, new medications, new insulins
Jun 02, 2017

IMPROVING SUCCESS FOR MANAGING DM IN INDIGENOUS PEOPLES (EDUCATING FOR EQUITY (E4E)- PART 2

At the conclusion of this session, in regards to Indigenous patients with diabetes, participants will be able to demonstrate:
  • Diabetes management that engages with key social factors facilitated by culturally informed approaches to supporting patients
  • Therapeutic relationship building that incorporates culturally attuned approaches and addresses discord arising from health care inequity
Jun 02, 2017

IMPROVING SUCCESS FOR MANAGING DM IN INDIGENOUS PEOPLES (EDUCATING FOR EQUITY (E4E)- PART 1

At the conclusion of this session, in regards to Indigenous patients with diabetes, participants will be able to demonstrate:
  • Diabetes management that engages with key social factors facilitated by culturally informed approaches to supporting patients
  • Therapeutic relationship building that incorporates culturally attuned approaches and addresses discord arising from health care inequity

1 2 Next>

 

 

Copyright © 2002-2019 Continuing Professional Development (CPD) Office,
Faculty of Medicine, McGill University